导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.08% | 338/1050 |
| 近一周 | 0.34% | 238/1104 |
| 近一月 | -1.04% | 231/1103 |
| 近一季 | -2.75% | 383/1092 |
| 近半年 | 3.97% | 350/1070 |
| 近一年 | 13.88% | 319/1018 |
| 近两年 | 86.32% | 267/926 |
| 近三年 | 49.34% | 270/834 |
| 成立以来 | 114.39% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.24% 506/1070 |
24.69% 338/1101 |
- - |
- - |
| 2025 | 39.60% 333/1065 |
2.82% 559/1014 |
2.70% 457/1038 |
30.43% 352/1050 |
1.35% 361/1065 |
| 2024 | 6.12% 390/1011 |
3.42% 149/960 |
-6.16% 702/983 |
11.22% 525/991 |
-1.69% 425/1011 |
| 2023 | -5.35% 209/952 |
5.12% 319/880 |
-0.48% 215/895 |
-2.26% 167/915 |
-7.44% 719/952 |
| 2022 | -10.98% 97/867 |
-10.12% 108/773 |
4.32% 560/806 |
-7.31% 115/845 |
2.43% 304/867 |
| 2021 | 11.46% 223/740 |
4.68% 51/580 |
5.73% 456/659 |
2.56% 173/704 |
-1.80% 507/740 |
| 2020 | 39.07% 302/554 |
-5.26% 299/419 |
14.41% 365/466 |
14.44% 155/517 |
12.13% 289/554 |
| 2019 | 31.16% 283/410 |
25.29% 685/1146 |
-4.06% 649/1228 |
1.06% 305/390 |
7.97% 238/410 |
| 2018 | - - |
- - |
- - |
-0.94% 224/1000 |
-11.10% 403/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 博时量化多策略股票A VS. 东吴新产业精选股票A(580008) |